These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27325879)

  • 1. Standardization of compounded oral liquids for pediatric patients in Michigan.
    Engels MJ; Ciarkowski SL; Rood J; Wang B; Wagenknecht LD; Dickinson CJ; Stevenson JG
    Am J Health Syst Pharm; 2016 Jul; 73(13):981-90. PubMed ID: 27325879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variability in compounding of oral liquids for pediatric patients: a patient safety concern.
    Rood JM; Engels MJ; Ciarkowski SL; Wagenknecht LD; Dickinson CJ; Stevenson JG
    J Am Pharm Assoc (2003); 2014; 54(4):383-9. PubMed ID: 25063260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Devices for securing and administering pediatric compounded oral liquids: survey results from French university hospitals.
    Cavelier M; Hervouët C; Varin R; Gondé H
    Eur J Pediatr; 2024 Jun; 183(6):2805-2810. PubMed ID: 38573361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Encouraging pharmacist intervention and standardization of labeling and dispensing of oral liquid medications.
    Endriukaitis LA; Briars LA; Bursua AJ
    J Am Pharm Assoc (2003); 2017; 57(3):412-413. PubMed ID: 28506399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A High-Demanding Strategy to Ensure the Highest Quality Standards of Oral Liquid Individualized Medicines for Pediatric Use.
    Suárez-González J; Santoveña-Estévez A; Armijo-Ruíz S; Castillo A; Fariña JB
    AAPS PharmSciTech; 2019 Jun; 20(5):208. PubMed ID: 31161450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Errors detected in pediatric oral liquid medication doses prepared in an automated workflow management system.
    Bledsoe S; Van Buskirk A; Falconer RJ; Hollon A; Hoebing W; Jokic S
    Am J Health Syst Pharm; 2018 Feb; 75(3):127-131. PubMed ID: 29371193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Updating formulations for compounded oral liquid medications in a university health system.
    Stumpf JL; Leja N; Ciarkowski SL; Salah S; Schaeffler KL
    Am J Health Syst Pharm; 2018 Sep; 75(18):1394-1398. PubMed ID: 30006436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmaceutical Compounding in Portuguese Community Pharmacies: CHARACTERIZATION AND FUTURE PERSPECTIVES.
    Palmeira-de-Oliveira R; Macedo M; Machado RM; Pacheco AF; Palmeira-de-Oliveira A; Martinez-de-Oliveira J; Duarte P
    Int J Pharm Compd; 2016; 20(2):114-22. PubMed ID: 27323423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Practical guidelines to ensure the quality of compounded preparations in community pharmacies].
    Wauters K; Vandeputte A; De Paepe K
    J Pharm Belg; 2017 Mar; (1):14-24. PubMed ID: 30281230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compounding practices in a Portuguese community pharmacy.
    Reis M; Carvalho M; Rodrigues A
    Int J Pharm Compd; 2014; 18(5):392-5. PubMed ID: 25577888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants and frequency of pharmaceutical compounding in pharmacy practice in Palestine.
    Zaid AN; Al-Ramahi R; Shahed Q; Saleh B; Elaraj J
    Int J Pharm Pract; 2012 Feb; 20(1):9-14. PubMed ID: 22236175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterizing specialized compounding in community pharmacies.
    Giam JA; McLachlan AJ; Krass I
    Res Social Adm Pharm; 2012; 8(3):240-52. PubMed ID: 21824824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacists' perspectives of the current status of pediatric asthma management in the U.S. community pharmacy setting.
    Elaro A; Bosnic-Anticevich S; Kraus K; Farris KB; Shah S; Armour C; Patel MR
    Int J Clin Pharm; 2017 Aug; 39(4):935-944. PubMed ID: 28497209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacists' adoption into practice of newly reclassified medicines from diverse therapeutic areas in Scotland: a quantitative study of factors associated with decision-making.
    Paudyal V; Hansford D; Cunningham S; Stewart D
    Res Social Adm Pharm; 2014; 10(1):88-105. PubMed ID: 23665077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specialty compounding for improved patient care: 2006 national survey of compounding pharmacists.
    Huffman DC; Holmes ER
    Int J Pharm Compd; 2008; 12(1):74-82. PubMed ID: 23969574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perceptions of pharmaceutical care among pharmacists offering compounding services.
    Yancey V; Yakimo R; Perry A; McPherson TB
    J Am Pharm Assoc (2003); 2008; 48(4):508-14. PubMed ID: 18653427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Trends and Emerging Priorities in Compounded Preparations for Children.
    Parrish RH
    Int J Pharm Compd; 2018; 22(5):358-366. PubMed ID: 30384335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Improving the quality of compounded medicines through self-assessment: proof of concept].
    Wauters K; Fierens C; Corthout J; Sarre S; Saevels J
    J Pharm Belg; 2014 Jun; (2):26-33. PubMed ID: 25055453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extemporaneous compounding of oral liquid dosage formulations and alternative drug delivery methods for anticancer drugs.
    Lam MS
    Pharmacotherapy; 2011 Feb; 31(2):164-92. PubMed ID: 21275495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The status of the performance of medication reviews in German community pharmacies and assessment of the practical performance.
    Greißing C; Kössler K; Freyer J; Hüter L; Buchal P; Schiek S; Bertsche T
    Int J Clin Pharm; 2016 Dec; 38(6):1425-1435. PubMed ID: 27783313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.